North America Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Country 2024-2032

North America Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A1682

Market Overview:

The North America hormone replacement therapy market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 4.5 Billion
Market Forecast in 2032
US$ 6.9 Billion
Market Growth Rate 2024-2032 4.7%


Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.

North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.

North America Hormone Replacement Therapy Market

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the North America hormone replacement therapy market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on product, route of administration and type of disease.

  • Key Regions Analysed
    • United States
    • Canada
    • Mexico
       
  • Analysis for Each Country
     
  • Market by Product
    • Estrogen Replacement Therapy
    • Human Growth Hormone Replacement Therapy
    • Thyroid Replacement Therapy
    • Testosterone Replacement Therapy
    • Others
       
  • Market by Route of Administration
    • Oral
    • Parenteral
    • Transdermal
       
  • Market by Type of Disease
    • Menopause
    • Hypothyroidism
    • Male Hypogonadism
    • Growth Hormone Deficiency
    • Others
       
  • Value Chain Analysis
  • Key Drivers and Challenges
  • Porters Five Forces Analysis
  • PESTEL Analysis
  • Government Regulations
  • Competitive Landscape
    • Competitive Structure
    • Key Player Profiles

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Route of Administration, Type of Disease, Country
Countries Covered United States, Canada, Mexico
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the North America hormone replacement therapy market performed so far and how will it perform in the coming years?
  • What are the key regions in the North America hormone replacement therapy market?
  • What has been the impact of COVID-19 on the North America hormone replacement therapy market?
  • What is the breakup of the North America hormone replacement therapy market on the basis of product?
  • What is the breakup of the North America hormone replacement therapy market on the basis of route of administration?
  • What is the breakup of the North America hormone replacement therapy market on the basis of type of disease?
  • What are the various stages in the value chain of the North America hormone replacement therapy industry?
  • What are the key driving factors and challenges in the North America hormone replacement therapy industry?
  • What is the structure of the North America hormone replacement therapy industry and who are the key players?
  • What is the degree of competition in the North America hormone replacement therapy industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
North America Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Country 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials